Printer Friendly

Browse Insulin glargine topic

Articles

1-90 out of 90 article(s)
Title Author Type Date Words
Mylan, Biocon subsidiary announce U.S. launch of Semglee. Aug 31, 2020 202
Poly (ADP-Ribose) Polymerase 1 Protein Expression in Normal Pancreas and Pancreatic Adenocarcinoma. Castiglione, Roberto; Calogero, Aldo E.; Vicari, Enzo; Calabrini, Giovanna; Cosentino, Anna; D'Agati Jul 31, 2020 2342
Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura. Iakovis, Nikolaos; Xanthopoulos, Andrew; Chamaidi, Aikaterini; Papamichalis, Michail; Dimos, Apostol Jun 30, 2020 2289
Novo Nordisk's once-weekly insulin icodec showed comparable efficacy and safety to once-daily insulin glargine U100 in phase 2 clinical trial. Jun 15, 2020 263
Novo Nordisk's once-weekly insulin icodec showed comparable efficacy and safety to once-daily insulin glargine U100 in phase 2 clinical trial. Jun 15, 2020 267
Novo Nordisk Finds Insulin Icodec Comparable To Insulin Glargine U100. Jun 15, 2020 261
Mylan and Biocon win FDA approval for Semglee (insulin glargine injection) for type 2 and type 1 diabetes. Jun 12, 2020 263
Mylan and Biocon win FDA approval for Semglee (insulin glargine injection) for type 2 and type 1 diabetes. Jun 12, 2020 261
Mylan and Biocon win FDA approval for Semglee (insulin glargine injection) for type 2 and type 1 diabetes. Jun 12, 2020 265
Lannett provides update on clinical advancement of similar insulin glargine. Jun 11, 2020 237
Mylan Cheers US Patent Board Shutting Down Sanofi Over Lantus Patents. Jun 1, 2020 461
PTAB rules in favor of Mylan, invalidating Sanofi Lantus SoloSTAR patents. May 29, 2020 193
Hepatocellular Glycogen Accumulation in the Setting of Poorly Controlled Type 1 Diabetes Mellitus: Case Report and Review of the Literature. Aluko, Atinuke; Enofe, Ikponmwosa; Burch, Jacob; Yam, Julie; Khan, Nazia Mar 31, 2020 3981
Recurrent Acute Coronary Syndromes in a Patient with Idiopathic Thrombocytopenic Purpura. Iakovis, Nikolaos; Xanthopoulos, Andrew; Chamaidi, Aikaterini; Papamichalis, Michail; Dimos, Apostol Mar 31, 2020 2288
Mylan wins in district court dispute against Sanofi's Lantus patent. Mar 10, 2020 318
Novo Nordisk releases 'Ryzodeg' for management of type 2 diabetes. Daily News Egypt Mar 7, 2020 526
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes. Nomoto, Hiroshi; Gurlo, Tatyana; Rosenberger, Madeline; Girgis, Mark D.; Dry, Sarah; Butler, Peter C Dec 31, 2019 3741
Biosimilar drugs to provide safe, effective treatment. Dec 13, 2019 1606
Chinese & Global Insulin Glargine Market Insights, Analysis & Forecast 2019-2024. Dec 10, 2019 883
Benzinga Pro's Top 5 Stocks To Watch For Wed., Dec. 4, 2019: CRM, WDAY, GPRO, LCI, SPY. Benzinga Newsdesk Dec 4, 2019 305
Biosimilar Market 2019 Size, Share, Growth, Trends, Global Opportunity Analysis And Industry Forecast to 2024. Industry overview Nov 25, 2019 578
Insulin Glargine Market Research Report 2019 Analysis Revealing Key Drivers & Growth Trends, Global Industry Size, Share, Trends, Top Companies, Regional Statistics By 2026. Report Nov 11, 2019 1068
Sanofi - Positive results in Phase 3 trial for Toujeo[R] in children and adolescents with type 1 diabetes - 4/11/2019. Nov 7, 2019 409
Eli Lilly and Company UK (NYSE:LLY) - Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance[R] - 4/11/2019. Nov 6, 2019 508
Boehringer Ingelheim and Eli Lilly to modernise present collaboration. Nov 6, 2019 207
Boehringer Ingelheim and Eli Lilly to modernise present collaboration. Nov 6, 2019 203
Biocon's Biologics drug products facility gets nod from US FDA. ANI Nov 5, 2019 334
Sanofi (NYSE: SNY). Oct 14, 2019 5498
TYPE 2 DIABETES: 'More serious trajectory' seen in adolescents. Otto, M. Alexander Oct 1, 2019 1742
New Diagnosis Diabetes and Deep Venous Thrombosis with Glucagonoma Cases; Case Report. Karaaslan, Tahsin; Karatoprak, Cumali Oct 1, 2019 2026
Sanofi (NYSE: SNY). Sep 23, 2019 5499
Novo Nordisk says Tresiba showed overall lower risk of hypoglycaemia in CONCLUDE. Sep 19, 2019 174
Sanofi (NYSE: SNY). Sep 17, 2019 5499
Sanofi (NYSE:SNY). Sep 11, 2019 5499
Sanofi (NYSE:SNY). Sep 3, 2019 5499
Early Treatment with Empagliflozin and GABA Improves [beta]-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice. Daems, Caroline; Welsch, Sophie; Boughaleb, Hasnae; Vanderroost, Juliette; Robert, Annie; Sokal, Eti Aug 31, 2019 9093
Sanofi (NYSE: SNY). Aug 27, 2019 5499
Sanofi (NYSE:SNY). Aug 20, 2019 5499
Sanofi (NYSE:SNY). Aug 13, 2019 5499
Sanofi (NYSE:SNY). Aug 6, 2019 5499
Nocturnal Glycemic Control with New Insulin Glargine 300 U/mL. Yu, Neng Chun Jul 31, 2019 3449
Low-Energy Extracorporeal Shock Wave Therapy Ameliorates Kidney Function in Diabetic Nephropathy. Hsiao, Chang-Chun; Huang, Wei-Han; Cheng, Kuang-Hung; Lee, Chien-Te Jul 31, 2019 5096
Sanofi (NYSE: SNY). Jul 29, 2019 5498
Sanofi (NYSE: SNY). Jul 22, 2019 5498
Sanofi (NYSE:SNY). Jul 16, 2019 5498
Sanofi (NYSE:SNY). Jul 8, 2019 5499
Sanofi (NYSE:SNY). Jul 4, 2019 5499
Sanofi (NYSE:SNY). Jun 24, 2019 5499
Sanofi (NYSE:SNY). Jun 18, 2019 5499
Sanofi (NYSE:SNY). Jun 13, 2019 5499
Lannett commences clinical trial of biosimilar insulin glargine. Clinical report Jun 5, 2019 180
Sanofi (NYSE:SNY). Jun 4, 2019 5499
HDR Syndrome Accompanying Type 1 Diabetes Mellitus and Hypopituitarism. Can, Mustafa; Karakurt, Feridun; Kocabas, Muhammed; Cordan, Ilker; Karakose, Melia; Kulaksizoglu, Mu May 31, 2019 2206
Sanofi (NYSE:SNY). May 29, 2019 5499
Sanofi (NYSE:SNY). May 20, 2019 5498
Sanofi (NYSE:SNY). May 14, 2019 5501
Sanofi (NYSE:SNY). May 6, 2019 5498
Sanofi (NYSE:SNY). Apr 29, 2019 5499
Sanofi (NYSE: SNY). Apr 23, 2019 5496
Sanofi (NYSE:SNY). Apr 15, 2019 5499
A suicide attempt, or something else? Blacker, Caren J.; Mbughuni, Michael M.; Olsen, Mark W. Clinical report Mar 1, 2019 2674
Bariatric surgery + medical therapy: Effective Tx for T2DM? Short-term studies have indicated "Yes," but does a long-term randomized controlled trial give it a thumbs up? Roberson, Kortnee Y.; Van Gompel, Emily White; Jarrett, Jennie B. Report Mar 1, 2019 1587
A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease. Mohammadi-Shemirani, Pedrum; Sjaarda, Jennifer; Gerstein, Hertzel C.; Treleaven, Darin J.; Walsh, Mi Mar 1, 2019 6794
Sanofi wins US FDA approval for the expanded use of Soliqua 100/33 as add-on to diet and exercise for adults with type 2 diabetes. Feb 28, 2019 282
Sanofi wins US FDA approval for the expanded use of Soliqua 100/33 as add-on to diet and exercise for adults with type 2 diabetes. Feb 28, 2019 278
Expert calls for better ways to preserve beta-cell function. Brunk, Doug Jan 1, 2019 671
Diabetic Ketoacidosis Occurring in Patient on Newly Started Insulin Glargine U300. Kirac, Cem Onur; Ipekci, Suleyman Hilmi; Kebapcilar, Levent Case study Dec 1, 2018 1104
Insulin Glargine 300 Safe, Effective in Seniors With T2DM; Significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100. Jun 26, 2018 269
Efficacy and Safety of Insulin Degludec versus Insulin Glargine: A Systematic Review and Meta-Analysis of Fifteen Clinical Trials. Liu, Wei; Yang, Xiaojie; Huang, Jing Jan 1, 2018 8308
Black Esophagus: A Rare Case of Acute Esophageal Necrosis Induced by Diabetic Ketoacidosis in a Young Adult Female. Field, Zachary; Kropf, Jacqueline; Lytle, Meghan; Castaneira, Giselle; Madruga, Mario; Carlan, S.J. Jan 1, 2018 1954
Effects of Pravastatin on Type 1 Diabetic Rat Heart with or without Blood Glycemic Control. Min, Jeong Jin; Shin, Byung-Seop; Lee, Jong-Hwan; Jeon, Yunseok; Ryu, Dae Kyun; Kim, Sojin; Shin, Yo Report Jan 1, 2018 5477
Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature. Vargas-Uricoechea, Hernando Report Jan 1, 2018 29443
A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes. Lin, Shuo; Chen, Mu; Chen, Wanling; Lin, Keyi; Mu, Panwei; Zhu, Bilian; Xu, Wen; Wang, Manman; Weng, Report Jan 1, 2018 7498
Euglycemic Diabetic Ketoacidosis in the ICU: 3 Case Reports and Review of Literature. Lucero, Pablo; Chapela, Sebastian Jan 1, 2018 4500
Diabetic Myonecrosis: A Diagnostic and Treatment Challenge in Longstanding Diabetes. Lawrence, Lima; Tovar-Camargo, Oscar; Lansang, M. Cecilia; Makin, Vinni Clinical report Jan 1, 2018 1930
Isoproterenol Induced Insulin Resistance Leading to Diabetic Ketoacidosis in Type 1 Diabetes Mellitus. Hoff, Ryan; Koh, Chung-Kay Jan 1, 2018 1266
A Case of Factitious Hyperglycemia in a Patient on Intravenous Ascorbic Acid. Sharma, Eliza; Resta, Christine; Park, Patricia Report Jan 1, 2018 1600
Diabetes Mellitus with Poor Glycemic Control as a Consequence of Inappropriate Injection Technique. Poudel, Ramesh Sharma; Shrestha, Shakti; Bhandari, Sushma; Piryani, Rano Mal; Adhikari, Shital Jan 1, 2018 2675
Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes. Okuroglu, Nalan; Sertbas, Meltem; Ozdemir, Ali Jan 1, 2018 1294
Anticoagulant Related Nephropathy Induced by Dabigatran. Sharfuddin, Nazia; Nourbakhsh, Mahra; Box, Alan; Benediktsson, Hallgrimur; Muruve, Daniel A. Jan 1, 2018 3610
A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4. Irawan, Hendry; Semadi, I. Nyoman; Widiana, I. Gde Raka Jan 1, 2018 4380
Progress towards the replacement of the rabbit blood sugar bioidentity assay by an in vitro test for batch release of insulins in quality control. Hack, Rudiger; Rueggeberg, Sabrina; Schneider, Lea; Mayert, Dirk; Tennagels, Norbert; Welte, Stefan; Sep 22, 2017 893
Dulaglutide plus insulin glargine lowers Hb[A.sub.1c] in type 2. Sullivan, Michele G. Oct 1, 2016 639
Innovations in insulin: insulin glargine U-300. Anderson, John E. Report Oct 1, 2016 4682
Insulin detemir causes lesser weight gain in comparison to insulin glargine: role on hypothalamic NPY and galanin. Zafar, Mohammad Ishraq; Hu, Cuining; Liu, Danfeng; Gao, Feng; Shafqat, Raja Adeel Report Jan 1, 2014 4943
Some reassuring evidence. Colhoun, Helen M. Brief article Oct 15, 2012 187
Metformin investigated as possible anticancer treatment. Tucker, Miriam E. Report Nov 1, 2009 519
Acute MI rates differ with two insulins. Mechcatie, Elizabeth Report Oct 15, 2009 334
Data linking glargine to cancer 'inconclusive'. Tucker, Miriam E. Clinical report Sep 1, 2009 1616
Long-acting insulin analogues' benefit questioned. Moon, Mary Ann Brief article Jun 1, 2007 252

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters